Eric M Poeschla MD

HIV/AIDS Medicine, International Health, Travel & Tropical, Microbiology

Professor of Medicine, Tim Gill Endowed Chair in HIV Research and Chief, Division of Infectious Diseases University of Colorado School of Medicine

Education & Training

University of California (San Diego) Medical CenterFellowship, Infectious Disease, 1990 - 1993
University of California (San Francisco)Residency, Internal Medicine, 1985 - 1987
Yale School of MedicineClass of 1985

PubMed

New COVID Variant XBB: Symptoms Doctors Are Seeing Right NowJanuary 6th, 2023
Nearly 30 Percent of Coloradans Testing for COVID Right Now Are Positive as Omicron SpreadsJanuary 12th, 2022
Colorado’s COVID Hospitalizations Still Trending up as State Surpasses 1 Million CasesJanuary 11th, 2022
Join now to see all

SARS-CoV-2 and Innate Immunity: Mechanisms of Resistance to Human InterferonsVA EASTERN COLORADO HEALTH CARE SYSTEM2023–2027
Introducing Restriction Factors Into The Genome Of An AIDS Virus Host SpeciesNational Institute Of Allergy And Infectious Diseases2012
Ledgf/P7 And HIV IntegrationNational Institute Of Allergy And Infectious Diseases2008–2012
Eicosanoid Gene TherapyNational Eye Institute2008–2011
Lentiviral Genome ProcessingNational Institute Of Allergy And Infectious Diseases2005–2008
Lentiviral Transgenesis Of The Aqueous Outflow TractNational Eye Institute2004–2007
Lentiviral Genome ProcessingNational Institute Of Allergy And Infectious Diseases2003
Lentiviral Transgenesis Of The Aqueous Outflow TractNational Eye Institute2003
Novel Lentiviral Vectors For Sustained Gene ExpressionNational Institute Of Allergy And Infectious Diseases2000–2002
Core--Gene TherapyNational Institute Of Allergy And Infectious Diseases1998–2001
Feline Immunodeficiency Virus VectorsNational Institute Of Allergy And Infectious Diseases1999